1)  HER-2
抗人表皮生长因子受体 HER-2
1.
A tumor-targeting recombinant fusion immunotoxin B-L-SEC2 was constructed by fusing staphylococcal enterotoxin C2(SEC2)and an anti-HER-2 single-chain Fv B1 through a peptide linker,and expressed in E.
用基因工程方法,将金黄色葡萄球菌肠毒素 C2 与抗人表皮生长因子受体 HER-2 单链抗体 scFv-B1,以一连接短肽连接,构建融合免疫毒素 B-L-SEC2,并用改进的新型表达载体 pASK75-EX,在大肠杆菌 BL21(ED3)中表达。
2)  HER-2
HER-2
1.
Expression and Correlation of HER-2, VEGF and CXCR4 in Rectal Cancer;
直肠癌中HER-2、VEGF与CXCR4的表达及相关性
2.
Relationship between HER-2 expression and age and axillary lymph nodes status in breast cancer;
乳腺癌组织HER-2表达与患者年龄及腋淋巴结转移相关性的研究
3.
Value of expression of HER-2 and Topo-Ⅱ in prediction of response to neoadjuvant chemotherapy in breast cancer;
HER-2和Topo-Ⅱ蛋白表达对乳腺癌新辅助化疗疗效的预测价值
3)  Her-2 peptide
Her-2多肽
1.
CIK and DC pulsed with antigen Her-2 peptide were then co-cultured to prepare CIK-DC co-culture system(DCIK-P).
本文观察利用树突状细胞(DC)呈递肿瘤抗原(Her-2多肽)的特性提高DCIK细胞对乳腺癌细胞的杀伤活性。
4)  HER-2/oncogene
HER-2/癌基因
5)  Her-2 gene
Her-2基因
1.
The expression of the E1A and Her-2 gene was.
方法将人宫颈癌细胞(Hela)、转染空载体纳米粒的人宫颈癌细胞(Hela-vector)及转染E1A基因的人宫颈癌细胞(Hela-E1A)分别给以0、2、4、6和8Gy的6MV-X线照射,用集落形成法计算细胞存活分数及放射增敏比(SER),检测E1A基因对人宫颈癌细胞对放射线敏感性的影响;采用RT-PCR检测E1A基因的表达以及E1A基因对Her-2基因表达的影响,采用流式细胞术检测E1A基因对细胞周期的影响。
2.
Objective To explore the relevance among HER-2 gene amplification,microvessel density(MVD),tumor size,lymph node metastasis and histological grading,as well as to discuss the significance of the levels of HER-2 gene amplification and MVD on the prognostic judgment of breast cancer.
目的探讨乳腺癌原癌基因HER-2基因扩增与肿瘤大小、淋巴结转移、组织学分级、微血管密度(MVD)等有无相关性,并初步了解HER-2的扩增水平和MVD对乳腺癌的预后判断有无一致性。
6)  HER-2 and Bcl-2 genes
Bcl-2、HER-2基因
参考词条
补充资料：表皮生长因子受体


表皮生长因子受体


为膜受体酪氨酸激酶，因其上有受体分子而表现酶的活性。对其形成的调节机制尚不清楚。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。